Background
Hepatitis C positive volunteers are needed to participate in a four week research study regarding an investigational Hepatitis C Polymerase Inhibitor. This is a new class of drugs to treat Hep C infection.

Participants will be paid up to $2,400

If you qualify, you will receive study-related medical examinations and lab tests along with the monetary compensation.

Inclusion Criteria
1) Chronic infection with Hepatitis C genotype 1
2) No prior treatment with Interferon
3) In otherwise good health
4) HIV Negative

For more information please contact Dr. Jacob Lalezari of Quest Clinical Research at (415) 353-0800